Abbott Laboratories said it received a subpoena last month from the US Justice Department in connection with its sales and marketing of bile-duct stents.
The government is investigating whether the company violated civil or criminal laws in connection with Medicare and Medicaid reimbursements paid to third parties, Abbott of Abbott Park, Illinois, said today in a filing with the US Securities and Exchange Commission.
The company said it doesn’t anticipate a “material adverse effect” on company finances.
The US Food and Drug Administration warned about illegal sales of stents when it met in March 2007 with the companies that make the devices, among them Boston Scientific Corp, Alveolus Inc and Johnson & Johnson.
Boston Scientific, based in Natick, Massachusetts said in February the Justice Department was investigating whether the company and other suppliers were illegally promoting the devices for unapproved uses.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
